BLCO Articles, Bausch + Lomb Corporation

Oppenheimer initiated coverage on Clearside Biomedical Inc (NASDAQ:CLSD), a biopharmaceutical company focused on delivering therapies to the back o...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...

A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc.‘s (NASD...

Corporate earnings came to the market’s rescue in the past week, helping to overcome rate fears. As we look ahead to the unfolding week, it r...

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-qu...

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday. Shares of Toll Brothers, Inc. (NYSE: TOL) gained duri...

Papa will lead Emergent into a new era of focusing on protecting public health, returning to growth and paying down the company's debt GAIT...

Wall Street remains subdued following Tuesday’s sell-off, primarily driven by small-cap and tech stocks. All eyes are now on Nvidia Corp...

Eye health products company Bausch + Lomb Corp (NYSE:BLCO) is scheduled to release its fourth-quarter and full-year 2023 financial result...

Stocks experienced a modest surge amid the Federal Open Market Committee meeting Wednesday. The central bank is widely expected to leave interest r...